Diabetes Care is available free to NHS staff 3 months after publication. Articles with links provided are available earlier. You can also order individual articles using the Inter-Library Loan system if you need them quicker. Please contact the library for further details.
Volume 31, Number 7
Clinical Care/Education/Nutrition/Psychosocial Research
Isolated Hyperglycemia at 1 Hour on Oral Glucose Tolerance Test in Pregnancy Resembles Gestational Diabetes Mellitus in Predicting Postpartum Metabolic Dysfunction
Ravi Retnakaran, Ying Qi, Mathew Sermer, Philip W. Connelly, Bernard Zinman, and Anthony J.G. Hanley
Effect of Supervised Progressive Resistance-Exercise Training Protocol on Insulin Sensitivity, Glycemia, Lipids, and Body Composition in Asian Indians With Type 2 Diabetes
Anoop Misra, Narendra K. Alappan, Naval K. Vikram, Kashish Goel, Nidhi Gupta, Kanchan Mittal, Suryaprakash Bhatt, and Kalpana Luthra
Long-Term Outcome and Disability of Diabetic Patients Hospitalized for Diabetic Foot Ulcers: A 6.5-year follow-up study
Edouard Ghanassia, Laetitia Villon, Jean-François Thuan dit Dieudonné, Catherine Boegner, Antoine Avignon, and Ariane Sultan
The Prospective Contribution of Hostility Characteristics to High Fasting Glucose Levels: The moderating role of marital status
Biing-Jiun Shen, Amanda J. Countryman, Avron Spiro, III, and Raymond Niaura
Weight Loss Strategies Associated With BMI in Overweight Adults With Type 2 Diabetes at Entry Into the Look AHEAD (Action for Health in Diabetes) Trial
Hollie A. Raynor, Robert W. Jeffery, Andrea M. Ruggiero, Jeanne M. Clark, Linda M. Delahanty for the Look AHEAD (Action for Health in Diabetes) Research Group
Adjust to Target in Type 2 Diabetes: Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine
Richard M. Bergenstal, Mary Johnson, Margaret A. Powers, Alan Wynne, Aleksandra Vlajnic, Priscilla Hollander, and Marc Rendell
Intake of Fruit, Vegetables, and Fruit Juices and Risk of Diabetes in Women
Lydia A. Bazzano, Tricia Y. Li, Kamudi J. Joshipura, and Frank B. Hu
Dietary Behaviors Predict Glycemic Control in Youth With Type 1 Diabetes
Sanjeev N. Mehta, Lisa K. Volkening, Barbara J. Anderson, Tonja Nansel, Jill Weissberg-Benchell, Tim Wysocki, Lori M.B. Laffel for the Family Management of Childhood Diabetes Study Steering Committee
Long-Term Follow-Up of Oral Glucose Tolerance Test–Derived Glucose Tolerance and Insulin Secretion and Insulin Sensitivity Indexes in Subjects With Glucokinase Mutations (MODY2)
Delphine Martin, Christine Bellanné-Chantelot, Inge Deschamps, Philippe Froguel, Jean-Jacques Robert, and Gilberto Velho
Improving Treatment of Depression Among Latinos With Diabetes Using Project Dulce and IMPACT
Todd P. Gilmer, Chris Walker, Elizabeth D. Johnson, Athena Philis-Tsimikas, and Jürgen Unützer
Randomized Efficacy Trial of Early Preconception Counseling for Diabetic Teens (READY-Girls)
Denise Charron-Prochownik, Margaret Ferons-Hannan, Susan Sereika, and Dorothy Becker
Epidemiology/Health Services Research
Association Between Renal Failure and Foot Ulcer or Lower-Extremity Amputation in Patients With Diabetes
David J. Margolis, Ole Hofstad, and Harold I. Feldman
Trends in Diabetes, High Cholesterol, and Hypertension in Chronic Kidney Disease Among U.S. Adults: 1988–1994 to 1999–2004
Caroline S. Fox and Paul Muntner
Dietary Patterns, Insulin Resistance, and Incidence of Type 2 Diabetes in the Whitehall II Study
Sarah A. McNaughton, Gita D. Mishra, and Eric J. Brunner
Longitudinal Association of Glucose Metabolism With Retinopathy: Results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study
Robyn J. Tapp, Gabriella Tikellis, Tien Y. Wong, C. Alex Harper, Paul Z. Zimmet, Jonathan E. Shaw on behalf of the Australian Diabetes Obesity and Lifestyle Study Group
Plasma Carotenoids and Onset of Dysglycemia in an Elderly Population: Results of the Epidemiology of Vascular Ageing Study
Tasnime N. Akbaraly, Annick Fontbonne, Alain Favier, and Claudine Berr
Relationship Between Risk Factors and Mortality in Type 1 Diabetic Patients in Europe: The EURODIAB Prospective Complications Study (PCS)
Sabita S. Soedamah-Muthu, Nish Chaturvedi, Daniel R. Witte, Lynda K. Stevens, Massimo Porta, John H. Fuller for the EURODIAB Prospective Complications Study Group
Burden and Rates of Treatment and Control of Cardiovascular Disease Risk Factors in Obesity: The Framingham Heart Study
Esther A. Molenaar, Shih-Jen Hwang, Ramachandran S. Vasan, Diederick E. Grobbee, James B. Meigs, Ralph B. D'Agostino, Sr., Daniel Levy, and Caroline S. Fox
Periodontal Disease and Incident Type 2 Diabetes: Results from the First National Health and Nutrition Examination Survey and its Epidemiologic Follow-Up Study
Ryan T. Demmer, David R. Jacobs, Jr., and Moïse Desvarieux
Differences in the Pattern of Antibiotic Prescription Profile and Recurrence Rate for Possible Urinary Tract Infections in Women With and Without Diabetes
Caroline Schneeberger, Ronald P. Stolk, J. Hans DeVries, Peter M. Schneeberger, Ron M. Herings, and Suzanne E. Geerlings
Inflammation Among Women With a History of Gestational Diabetes Mellitus and Diagnosed Diabetes in the Third National Health and Nutrition Examination Survey
Catherine Kim, Yiling J. Cheng, and Gloria L. Beckles
Sex Disparities in the Treatment and Control of Cardiovascular Risk Factors in Type 2 Diabetes
Ioanna Gouni-Berthold, Heiner K. Berthold, Christos S. Mantzoros, Michael Böhm, and Wilhelm Krone
Pathophysiology/Complications
Trends in High-Risk HLA Susceptibility Genes Among Colorado Youth With Type 1 Diabetes
Kendra Vehik, Richard F. Hamman, Dennis Lezotte, Jill M. Norris, Georgeanna J. Klingensmith, Marian Rewers, and Dana Dabelea
Adipose Tissue Lipolysis Is Upregulated in Lean and Obese Men During Acute Resistance Exercise
Athanasios Chatzinikolaou, Ioannis Fatouros, Anatoli Petridou, Athanasios Jamurtas, Alexandra Avloniti, Ioannis Douroudos, George Mastorakos, Christina Lazaropoulou, Ioannis Papassotiriou, Symeon Tournis, Asimina Mitrakou, and Vassilis Mougios
Increased Shear Rate Resistance and Fastest Kinetics of Erythrocyte Aggregation in Diabetes Measured With Ultrasound
Guy Cloutier, Audrey Zimmer, François T.H. Yu, and Jean-Louis Chiasson
Too Much Glucagon, Too Little Insulin: Time course of pancreatic islet dysfunction in new-onset type 1 diabetes
Rebecca J. Brown, Ninet Sinaii, and Kristina I. Rother
Cardiovascular and Metabolic Risk
Global Coronary Heart Disease Risk Assessment of Individuals With the Metabolic Syndrome in the U.S.
Khiet C. Hoang, Heli Ghandehari, Victor A. Lopez, Michael G. Barboza, and Nathan D. Wong
Adipokines and Incident Type 2 Diabetes in an Aboriginal Canadian Population: The Sandy Lake Health and Diabetes Project
Sylvia H. Ley, Stewart B. Harris, Philip W. Connelly, Mary Mamakeesick, Joel Gittelsohn, Robert A. Hegele, Ravi Retnakaran, Bernard Zinman, and Anthony J.G. Hanley
Sex Differences in Diabetes Risk and the Effect of Intensive Lifestyle Modification in the Diabetes Prevention Program
Leigh Perreault, Yong Ma, Sam Dagogo-Jack, Edward Horton, David Marrero, Jill Crandall, Elizabeth Barrett-Connor for the Diabetes Prevention Program
Association of Intrauterine Exposure to Maternal Diabetes and Obesity With Type 2 Diabetes in Youth: The SEARCH Case-Control Study
Dana Dabelea, Elizabeth J. Mayer-Davis, Archana P. Lamichhane, Ralph B. D'Agostino, Jr., Angela D. Liese, Kendra S. Vehik, K.M. Venkat Narayan, Phillip Zeitler, and Richard F. Hamman
Retinol-Binding Protein 4 and Insulin Resistance in Polycystic Ovary Syndrome
Samantha K. Hutchison, Cheryce Harrison, Nigel Stepto, Caroline Meyer, and Helena J. Teede
Insulin Resistance and Hyperinsulinemia: You can't have one without the other
Sun H. Kim and Gerald M. Reaven
Tumor Necrosis Factor- Antagonism Improves Vasodilation During Hyperinsulinemia in Metabolic Syndrome
Manfredi Tesauro, Francesca Schinzari, Valentina Rovella, Domenico Melina, Nadia Mores, Angela Barini, Marco Mettimano, Davide Lauro, Micaela Iantorno, Michael J. Quon, and Carmine Cardillo
Assessment of Aortic Pulse Wave Velocity and Cardiac Diastolic Function in Subjects With and Without the Metabolic Syndrome: HDL cholesterol is independently associated with cardiovascular function
Stijntje D. Roes, Reza Alizadeh Dehnavi, Jos J.M. Westenberg, Hildo J. Lamb, Bart J.A. Mertens, Jouke T. Tamsma, and Albert de Roos
Hyperinsulinemia in African-American Adolescents Compared With Their American White Peers Despite Similar Insulin Sensitivity: A reflection of upregulated β-cell function?
Tamara S. Hannon, Fida Bacha, Yan Lin, and Silva A. Arslanian
Reviews/Commentaries/ADA Statements
Meta-Analysis
Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral Neuropathy: Findings from seven randomized, controlled trials across a range of doses
Roy Freeman, Edith Durso-DeCruz, and Birol Emir
Rosiglitazone and Risk of Cancer: A meta-analysis of randomized clinical trials
Matteo Monami, Caterina Lamanna, Niccolò Marchionni, and Edoardo Mannucci Diabetes Care 2008 31: 1455-1460.
Perspectives on the News
Approaches to Treatment of Pre-Diabetes and Obesity and Promising New Approaches to Type 2 Diabetes
Zachary T. Bloomgarden
Editorials
Death to Carbohydrate Counting?
Nichola J. Davis and Judith Wylie-Rosett
This week's Diabetes Bulletin...
...
Friday, 11 July 2008
Diabetes
Vol. 57 ; part 7
Perspectives in Diabetes:
Immunomodulation by Mesenchymal Stem Cells: A Potential Therapeutic Strategy for Type 1 Diabetes
Reza Abdi, Paolo Fiorina, Chaker N. Adra, Mark Atkinson, and Mohamed H. Sayegh
Neurophysiological Pathways to Obesity: Below Awareness and Beyond Individual Control
Deborah A. Cohen
Protein Kinase C Function in Muscle, Liver, and β-Cells and Its Therapeutic Implications for Type 2 Diabetes
Carsten Schmitz-Peiffer and Trevor J. Biden
Commentaries:
The Pol-e-Pill Finally Arrives
James A. Levine and Ronald M. Davis
Obesity: Increasing Awareness of Novel Environmental Factors
Kevin D. Niswender and Bettina M. Beech
Low-Affinity Major Histocompatibility Complex–Binding Peptides in Type 1 Diabetes
Eddie A. James and William W. Kwok
New Methodologies and Databases
Glucose Metabolism In Vivo in Four Commonly Used Inbred Mouse Strains
Eric D. Berglund, Candice Y. Li, Greg Poffenberger, Julio E. Ayala, Patrick T. Fueger, Shannon E. Willis, Marybeth M. Jewell, Alvin C. Powers, and David H. Wasserman
Metabolism
Plasma C5 Glucose–to–2H2O Ratio Does Not Provide an Accurate Assessment of Gluconeogenesis During Hyperinsulinemic-Euglycemic Clamps in Either Nondiabetic or Diabetic Humans
Rita Basu, Visvanathan Chandramouli, Betty Dicke, Bernard R. Landau, and Robert A. Rizza
Signal Transduction
Human Adenovirus Type 36 Enhances Glucose Uptake in Diabetic and Nondiabetic Human Skeletal Muscle Cells Independent of Insulin Signaling
Zhong Q. Wang, William T. Cefalu, Xian H. Zhang, Yongmei Yu, Jianhua Qin, Leslie Son, Pamela M. Rogers, Nazar Mashtalir, Justin R. Bordelon, Jianping Ye, and Nikhil V. Dhurandhar
Activation of Estrogen Receptor Is Crucial for Resveratrol-Stimulating Muscular Glucose Uptake via Both Insulin-Dependent and -Independent Pathways
Jen-Ying Deng, Po-Shiuan Hsieh, Jiung-Pang Huang, Long-Sheng Lu, and Li-Man Hung
Obesity Studies
Adiponectin Reduces Plasma Triglyceride by Increasing VLDL Triglyceride Catabolism
Liping Qiao, Chenhui Zou, Deneys R. van der Westhuyzen, and Jianhua Shao
Hormone-Sensitive Lipase Serine Phosphorylation and Glycerol Exchange Across Skeletal Muscle in Lean and Obese Subjects: Effect of β-Adrenergic Stimulation
Johan W.E. Jocken, Carsten Roepstorff, Gijs H. Goossens, Paula van der Baan, Marleen van Baak, Wim H.M. Saris, Bente Kiens, and Ellen E. Blaak
Blockade of 4 Integrin Signaling Ameliorates the Metabolic Consequences of High-Fat Diet–Induced Obesity
Chloé C. Féral, Jaap G. Neels, Christiane Kummer, Marina Slepak, Jerrold M. Olefsky, and Mark H. Ginsberg
Immunology and Transplantation
Weak Proinsulin Peptide–Major Histocompatibility Complexes Are Targeted in Autoimmune Diabetes in Mice
Matteo G. Levisetti, Danna M. Lewis, Anish Suri, and Emil R. Unanue
Protective Role of Programmed Death 1 Ligand 1 (PD-L1)in Nonobese Diabetic Mice: The Paradox in Transgenic Models
Chia-Jen Wang, Feng-Cheng Chou, Chi-Hong Chu, Jen-Chine Wu, Shih-Hua Lin, Deh-Ming Chang, and Huey-Kang Sytwu
Improved Vascular Engraftment and Graft Function After Inhibition of the Angiostatic Factor Thrombospondin-1 in Mouse Pancreatic Islets
Johan Olerud, Magnus Johansson, Jack Lawler, Nils Welsh, and Per-Ola Carlsson
Immunoglobulin-Like Transcript 3-Fc Suppresses T-Cell Responses to Allogeneic Human Islet Transplants in hu-NOD/SCID Mice
George Vlad, Vivette D. D'Agati, Qing-Yin Zhang, Zhuoru Liu, Eric K. Ho, Thalachallour Mohanakumar, Mark A. Hardy, Raffaello Cortesini, and Nicole Suciu-Foca
Islet Studies
Fructose-1,6-Bisphosphatase Overexpression in Pancreatic β-Cells Results in Reduced Insulin Secretion: A New Mechanism for Fat-Induced Impairment of β-Cell Function
Melkam Kebede, Jenny Favaloro, Jenny E. Gunton, D. Ross Laybutt, Margaret Shaw, Nicole Wong, Barbara C. Fam, Kathryn Aston-Mourney, Christian Rantzau, Anthony Zulli, Joseph Proietto, and Sofianos Andrikopoulos
MAPK Kinase Kinase-1 Is Essential for Cytokine-Induced c-Jun NH2-Terminal Kinase and Nuclear Factor-B Activation in Human Pancreatic Islet Cells
Dariush Mokhtari, Jason W. Myers, and Nils Welsh
Pathophysiology
Effect of Oral Amino Acids on Counterregulatory Responses and Cognitive Function During Insulin-Induced Hypoglycemia in Nondiabetic and Type 1 Diabetic People
Paolo Rossetti, Francesca Porcellati, Natalia Busciantella Ricci, Paola Candeloro, Patrizia Cioli, K. Sreekumaran Nair, Fausto Santeusanio, Geremia B. Bolli, and Carmine G. Fanelli
Circulating Retinol-Binding Protein-4 Concentration Might Reflect Insulin Resistance–Associated Iron Overload
José Manuel Fernández-Real, José María Moreno, and Wifredo Ricart
Protein Engineering Strategies for Sustained Glucagon-Like Peptide-1 Receptor–Dependent Control of Glucose Homeostasis
Kristen M. Picha, Mark R. Cunningham, Daniel J. Drucker, Ashok Mathur, Tatiana Ort, Michael Scully, Avery Soderman, Tracy Spinka-Doms, Vedrana Stojanovic-Susulic, Beth Ann Thomas, and Karyn T. O'Neil
Novel De Novo Mutation in Sulfonylurea Receptor 1 Presenting as Hyperinsulinism in Infancy Followed by Overt Diabetes in Early Adolescence
Maha Abdulhadi-Atwan, Jeremy D. Bushman, Sharona Tornovsky-Babaey, Avital Perry, Abdulsalam Abu-Libdeh, Benjamin Glaser, Show-Ling Shyng, and David H. Zangen
Complications
RAGE and Modulation of Ischemic Injury in the Diabetic Myocardium
Loredana G. Bucciarelli, Radha Ananthakrishnan, Yuying C. Hwang, Michiyo Kaneko, Fei Song, David R. Sell, Christopher Strauch, Vincent M. Monnier, Shi Fang Yan, Ann Marie Schmidt, and Ravichandran Ramasamy
Hyperglycemia-Induced Reactive Oxygen Species Toxicity to Endothelial Cells Is Dependent on Paracrine Mediators
Julia V. Busik, Susanne Mohr, and Maria B. Grant
Serum Heat Shock Protein 27 and Diabetes Complications in the EURODIAB Prospective Complications Study: A Novel Circulating Marker for Diabetic Neuropathy
Gabriella Gruden, Graziella Bruno, Nish Chaturvedi, Davina Burt, Casper Schalkwijk, Silvia Pinach, Coen D. Stehouwer, Daniel R. Witte, John H. Fuller, Paolo Cavallo Perin, and the EURODIAB Prospective Complications Study Group
Genetics
Haplotype Structure of the ENPP1 Gene and Nominal Association of the K121Q Missense Single Nucleotide Polymorphism With Glycemic Traits in the Framingham Heart Study
Elliot S. Stolerman, Alisa K. Manning, Jarred B. McAteer, Josée Dupuis, Caroline S. Fox, L. Adrienne Cupples, James B. Meigs, and Jose C. Florez
Diabetes Susceptibility in the Canadian Oji-Cree Population Is Moderated by Abnormal mRNA Processing of HNF1A G319S Transcripts
Lorna W. Harries, Melissa J. Sloman, Elizabeth A.C. Sellers, Andrew T. Hattersley, and Sian Ellard
Association Analysis of Type 2 Diabetes Loci in Type 1 Diabetes
Hui-Qi Qu, Struan F.A. Grant, Jonathan P. Bradfield, Cecilia Kim, Edward Frackelton, Hakon Hakonarson, and Constantin Polychronakos
Association of FTO With Obesity-Related Traits in the Cebu Longitudinal Health and Nutrition Survey (CLHNS) Cohort
Amanda F. Marvelle, Leslie A. Lange, Li Qin, Linda S. Adair, and Karen L. Mohlke
Evaluation of the Association of IGF2BP2 Variants With Type 2 Diabetes in French Caucasians
Konsta Duesing, Ghazaleh Fatemifar, Guillaume Charpentier, Michel Marre, Jean Tichet, Serge Hercberg, Beverley Balkau, Philippe Froguel, and Fernando Gibson
Perspectives in Diabetes:
Immunomodulation by Mesenchymal Stem Cells: A Potential Therapeutic Strategy for Type 1 Diabetes
Reza Abdi, Paolo Fiorina, Chaker N. Adra, Mark Atkinson, and Mohamed H. Sayegh
Neurophysiological Pathways to Obesity: Below Awareness and Beyond Individual Control
Deborah A. Cohen
Protein Kinase C Function in Muscle, Liver, and β-Cells and Its Therapeutic Implications for Type 2 Diabetes
Carsten Schmitz-Peiffer and Trevor J. Biden
Commentaries:
The Pol-e-Pill Finally Arrives
James A. Levine and Ronald M. Davis
Obesity: Increasing Awareness of Novel Environmental Factors
Kevin D. Niswender and Bettina M. Beech
Low-Affinity Major Histocompatibility Complex–Binding Peptides in Type 1 Diabetes
Eddie A. James and William W. Kwok
New Methodologies and Databases
Glucose Metabolism In Vivo in Four Commonly Used Inbred Mouse Strains
Eric D. Berglund, Candice Y. Li, Greg Poffenberger, Julio E. Ayala, Patrick T. Fueger, Shannon E. Willis, Marybeth M. Jewell, Alvin C. Powers, and David H. Wasserman
Metabolism
Plasma C5 Glucose–to–2H2O Ratio Does Not Provide an Accurate Assessment of Gluconeogenesis During Hyperinsulinemic-Euglycemic Clamps in Either Nondiabetic or Diabetic Humans
Rita Basu, Visvanathan Chandramouli, Betty Dicke, Bernard R. Landau, and Robert A. Rizza
Signal Transduction
Human Adenovirus Type 36 Enhances Glucose Uptake in Diabetic and Nondiabetic Human Skeletal Muscle Cells Independent of Insulin Signaling
Zhong Q. Wang, William T. Cefalu, Xian H. Zhang, Yongmei Yu, Jianhua Qin, Leslie Son, Pamela M. Rogers, Nazar Mashtalir, Justin R. Bordelon, Jianping Ye, and Nikhil V. Dhurandhar
Activation of Estrogen Receptor Is Crucial for Resveratrol-Stimulating Muscular Glucose Uptake via Both Insulin-Dependent and -Independent Pathways
Jen-Ying Deng, Po-Shiuan Hsieh, Jiung-Pang Huang, Long-Sheng Lu, and Li-Man Hung
Obesity Studies
Adiponectin Reduces Plasma Triglyceride by Increasing VLDL Triglyceride Catabolism
Liping Qiao, Chenhui Zou, Deneys R. van der Westhuyzen, and Jianhua Shao
Hormone-Sensitive Lipase Serine Phosphorylation and Glycerol Exchange Across Skeletal Muscle in Lean and Obese Subjects: Effect of β-Adrenergic Stimulation
Johan W.E. Jocken, Carsten Roepstorff, Gijs H. Goossens, Paula van der Baan, Marleen van Baak, Wim H.M. Saris, Bente Kiens, and Ellen E. Blaak
Blockade of 4 Integrin Signaling Ameliorates the Metabolic Consequences of High-Fat Diet–Induced Obesity
Chloé C. Féral, Jaap G. Neels, Christiane Kummer, Marina Slepak, Jerrold M. Olefsky, and Mark H. Ginsberg
Immunology and Transplantation
Weak Proinsulin Peptide–Major Histocompatibility Complexes Are Targeted in Autoimmune Diabetes in Mice
Matteo G. Levisetti, Danna M. Lewis, Anish Suri, and Emil R. Unanue
Protective Role of Programmed Death 1 Ligand 1 (PD-L1)in Nonobese Diabetic Mice: The Paradox in Transgenic Models
Chia-Jen Wang, Feng-Cheng Chou, Chi-Hong Chu, Jen-Chine Wu, Shih-Hua Lin, Deh-Ming Chang, and Huey-Kang Sytwu
Improved Vascular Engraftment and Graft Function After Inhibition of the Angiostatic Factor Thrombospondin-1 in Mouse Pancreatic Islets
Johan Olerud, Magnus Johansson, Jack Lawler, Nils Welsh, and Per-Ola Carlsson
Immunoglobulin-Like Transcript 3-Fc Suppresses T-Cell Responses to Allogeneic Human Islet Transplants in hu-NOD/SCID Mice
George Vlad, Vivette D. D'Agati, Qing-Yin Zhang, Zhuoru Liu, Eric K. Ho, Thalachallour Mohanakumar, Mark A. Hardy, Raffaello Cortesini, and Nicole Suciu-Foca
Islet Studies
Fructose-1,6-Bisphosphatase Overexpression in Pancreatic β-Cells Results in Reduced Insulin Secretion: A New Mechanism for Fat-Induced Impairment of β-Cell Function
Melkam Kebede, Jenny Favaloro, Jenny E. Gunton, D. Ross Laybutt, Margaret Shaw, Nicole Wong, Barbara C. Fam, Kathryn Aston-Mourney, Christian Rantzau, Anthony Zulli, Joseph Proietto, and Sofianos Andrikopoulos
MAPK Kinase Kinase-1 Is Essential for Cytokine-Induced c-Jun NH2-Terminal Kinase and Nuclear Factor-B Activation in Human Pancreatic Islet Cells
Dariush Mokhtari, Jason W. Myers, and Nils Welsh
Pathophysiology
Effect of Oral Amino Acids on Counterregulatory Responses and Cognitive Function During Insulin-Induced Hypoglycemia in Nondiabetic and Type 1 Diabetic People
Paolo Rossetti, Francesca Porcellati, Natalia Busciantella Ricci, Paola Candeloro, Patrizia Cioli, K. Sreekumaran Nair, Fausto Santeusanio, Geremia B. Bolli, and Carmine G. Fanelli
Circulating Retinol-Binding Protein-4 Concentration Might Reflect Insulin Resistance–Associated Iron Overload
José Manuel Fernández-Real, José María Moreno, and Wifredo Ricart
Protein Engineering Strategies for Sustained Glucagon-Like Peptide-1 Receptor–Dependent Control of Glucose Homeostasis
Kristen M. Picha, Mark R. Cunningham, Daniel J. Drucker, Ashok Mathur, Tatiana Ort, Michael Scully, Avery Soderman, Tracy Spinka-Doms, Vedrana Stojanovic-Susulic, Beth Ann Thomas, and Karyn T. O'Neil
Novel De Novo Mutation in Sulfonylurea Receptor 1 Presenting as Hyperinsulinism in Infancy Followed by Overt Diabetes in Early Adolescence
Maha Abdulhadi-Atwan, Jeremy D. Bushman, Sharona Tornovsky-Babaey, Avital Perry, Abdulsalam Abu-Libdeh, Benjamin Glaser, Show-Ling Shyng, and David H. Zangen
Complications
RAGE and Modulation of Ischemic Injury in the Diabetic Myocardium
Loredana G. Bucciarelli, Radha Ananthakrishnan, Yuying C. Hwang, Michiyo Kaneko, Fei Song, David R. Sell, Christopher Strauch, Vincent M. Monnier, Shi Fang Yan, Ann Marie Schmidt, and Ravichandran Ramasamy
Hyperglycemia-Induced Reactive Oxygen Species Toxicity to Endothelial Cells Is Dependent on Paracrine Mediators
Julia V. Busik, Susanne Mohr, and Maria B. Grant
Serum Heat Shock Protein 27 and Diabetes Complications in the EURODIAB Prospective Complications Study: A Novel Circulating Marker for Diabetic Neuropathy
Gabriella Gruden, Graziella Bruno, Nish Chaturvedi, Davina Burt, Casper Schalkwijk, Silvia Pinach, Coen D. Stehouwer, Daniel R. Witte, John H. Fuller, Paolo Cavallo Perin, and the EURODIAB Prospective Complications Study Group
Genetics
Haplotype Structure of the ENPP1 Gene and Nominal Association of the K121Q Missense Single Nucleotide Polymorphism With Glycemic Traits in the Framingham Heart Study
Elliot S. Stolerman, Alisa K. Manning, Jarred B. McAteer, Josée Dupuis, Caroline S. Fox, L. Adrienne Cupples, James B. Meigs, and Jose C. Florez
Diabetes Susceptibility in the Canadian Oji-Cree Population Is Moderated by Abnormal mRNA Processing of HNF1A G319S Transcripts
Lorna W. Harries, Melissa J. Sloman, Elizabeth A.C. Sellers, Andrew T. Hattersley, and Sian Ellard
Association Analysis of Type 2 Diabetes Loci in Type 1 Diabetes
Hui-Qi Qu, Struan F.A. Grant, Jonathan P. Bradfield, Cecilia Kim, Edward Frackelton, Hakon Hakonarson, and Constantin Polychronakos
Association of FTO With Obesity-Related Traits in the Cebu Longitudinal Health and Nutrition Survey (CLHNS) Cohort
Amanda F. Marvelle, Leslie A. Lange, Li Qin, Linda S. Adair, and Karen L. Mohlke
Evaluation of the Association of IGF2BP2 Variants With Type 2 Diabetes in French Caucasians
Konsta Duesing, Ghazaleh Fatemifar, Guillaume Charpentier, Michel Marre, Jean Tichet, Serge Hercberg, Beverley Balkau, Philippe Froguel, and Fernando Gibson
Diabetic Medicine
Guest Editorial
Estimated average glucose (eAG): fit for purpose?
Eric S. Kilpatrick
Commentary from Copenhagen on the NICE guideline on management of diabetes and its complications from pre-conception to the postnatal period.Elisabeth R Mathiesen and Peter Damm
Letter
Methodology problems in using eGFR to investigate the prevalence of Renal Anaemia
Postprandial triglyceridaemia in men with impaired fasting glucose, impaired glucose tolerance and diabetes.
R. Oka, K. Yagi, S. Hifumi, S. Miyamoto, H. Mabuchi, M. Yamagishi, Y. Takeda, A. Inazu, A. Nohara, M. Kawashiri and J. Kobayashi
Original articles
Treatment of chronic diabetic foot ulcers with bemiparin: A randomised, triple-blind, placebo controlled, clinical trial M. Rullan, L. Cerdà, G. Frontera, L. Masmiquel and J. Llobera
Care Delivery
Glycaemic control and diabetes care utilization in young adults with Type 1 diabetes
Carina Sparud-Lundin, Ingbritt Öhrn, Ella Danielson Gun Forsander
A Comparison of Diabetes Clinics with Different Emphasis on Routine Care, Complications Assessment and Shared Care
NW Cheung DK Yue MA Kotowicz PA Jones and JR Flack
Treatment
Safety and Efficacy of Glargine compared with NPH Insulin for the Treatment of Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials
Lydia A. Bazzano, MD, PhD, Lauren J. Lee, PharmD, MS, Lizheng Shi, MsPharm, PhD, Kristi Reynolds, PhD, Jeffrey A. Jackson, MD and Vivian Fonseca, MD
Metabolism
Longitudinal Screening of Serum Lipids in Children and Adolescents with Type 1 Diabetes in a UK Clinic Population
Julie A Edge Tim James Brian Shine
Point-of-care testing as a tool for screening for diabetes and prediabetes.
Elaine Rush, Nic Crook and David Simmons
Variability of lipids in patients with type 2 diabetes taking statin treatment: implications for target setting.
Thozhukat Sathyapalan, Stephen L. Atkin, Eric S. Kilpatrick,
Effects of Fat Supplementation on Glycaemic Response and Gastric Emptying in Adolescents with Type 1 Diabetes
M Lodefalk, J Åman and P Bang
Metabolism
Childhood Body Mass Index (BMI), breastfeeding and risk of type 1 diabetes: findings from a longitudinal national birth cohort
Russell M Viner Peter C Hindmarsh Brent Taylor and Timothy J Cole
Combined association of maternal and paternal family history of diabetes on plasma leptin and adiponectin in overweight Hispanic children
Koebnick C, Kelly LA, Lane CJ, Roberts CK, Shaibi GQ, Toledo-Corral CM, Davis JN, Weigensberg MJ and Goran MI
Short reports
HbA1c: the case for using estimated average glucose (eAG)
Philip Home
Hypertriglyceridaemia is associated with an increased likelihood of albuminuria in extreme duration (> 50 years) Type 1 diabetes Manuscript DME-2008-00150C Daousi, SC Bain, AH Barnett and GV Gill
Plasma triglycerides and LDL-cholesterol are related in a parabolic fashion in the general population and patients with type 2 diabetes mellitus: long-term follow-up results from the Hoorn study
M.C.G.J. Brouwers, J.M. Dekker, M.M.J. van Greevenbroek, C.J.H. van der Kallen, R.J. Heine, T.W.A. de Bruin and C.D.A. Stehouwer
Review
NICE guidance on Diabetes in pregnancy: management of diabetes and its complications from pre-conception to the postnatal period. NICE clinical guideline 63. London, March 2008.
Case Report
Renal Failure and Rhabdomyolysis Associated With Sitagliptin and Simvastatin Use
David P. Kao, Holbrook E Kohrt, John Kugler
Psychological aspects
A LONGITUDINAL STUDY OF AFFECTIVE AND ANXIETY DISORDERS, DEPRESSIVE AFFECT AND DIABETES DISTRESS in ADULTS WITH TYPE 2 DIABETES
Lawrence Fisher, Marilyn M. Skaff, Joseph T. Mullan, Patricia Arean, Russell Glasgow and Umesh Masharani
PREVALENCE AND REASONS FOR INSULIN REFUSAL in BANGLADESHI PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES IN EAST LONDON
Hamida Khan, Shawarna S Lasker, Tahseen A Chowdhury
Psychological aspects
Symptoms of Depression Prospectively Predict Poorer Self-Care in Patients with Type 2 Diabetes
JS Gonzalez, SA Safren, LM Delahanty, E Cagliero, DJ Wexler, JB Meigs and RW Grant
The personal cost of diabetic foot disease in developing world a study from Pakistan.
Syed Mansoor Ali, Aslam Fareed, Syed Mujahid Humail, Abdul Basit, Muhammad Yakoob Ahmedani, Asher Fawwad, M. Phil and Zahid Miyan.
Treatment
Estimated average glucose (eAG): fit for purpose?
Eric S. Kilpatrick
Commentary from Copenhagen on the NICE guideline on management of diabetes and its complications from pre-conception to the postnatal period.Elisabeth R Mathiesen and Peter Damm
Letter
Methodology problems in using eGFR to investigate the prevalence of Renal Anaemia
Postprandial triglyceridaemia in men with impaired fasting glucose, impaired glucose tolerance and diabetes.
R. Oka, K. Yagi, S. Hifumi, S. Miyamoto, H. Mabuchi, M. Yamagishi, Y. Takeda, A. Inazu, A. Nohara, M. Kawashiri and J. Kobayashi
Original articles
Treatment of chronic diabetic foot ulcers with bemiparin: A randomised, triple-blind, placebo controlled, clinical trial M. Rullan, L. Cerdà, G. Frontera, L. Masmiquel and J. Llobera
Care Delivery
Glycaemic control and diabetes care utilization in young adults with Type 1 diabetes
Carina Sparud-Lundin, Ingbritt Öhrn, Ella Danielson Gun Forsander
A Comparison of Diabetes Clinics with Different Emphasis on Routine Care, Complications Assessment and Shared Care
NW Cheung DK Yue MA Kotowicz PA Jones and JR Flack
Treatment
Safety and Efficacy of Glargine compared with NPH Insulin for the Treatment of Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials
Lydia A. Bazzano, MD, PhD, Lauren J. Lee, PharmD, MS, Lizheng Shi, MsPharm, PhD, Kristi Reynolds, PhD, Jeffrey A. Jackson, MD and Vivian Fonseca, MD
Metabolism
Longitudinal Screening of Serum Lipids in Children and Adolescents with Type 1 Diabetes in a UK Clinic Population
Julie A Edge Tim James Brian Shine
Point-of-care testing as a tool for screening for diabetes and prediabetes.
Elaine Rush, Nic Crook and David Simmons
Variability of lipids in patients with type 2 diabetes taking statin treatment: implications for target setting.
Thozhukat Sathyapalan, Stephen L. Atkin, Eric S. Kilpatrick,
Effects of Fat Supplementation on Glycaemic Response and Gastric Emptying in Adolescents with Type 1 Diabetes
M Lodefalk, J Åman and P Bang
Metabolism
Childhood Body Mass Index (BMI), breastfeeding and risk of type 1 diabetes: findings from a longitudinal national birth cohort
Russell M Viner Peter C Hindmarsh Brent Taylor and Timothy J Cole
Combined association of maternal and paternal family history of diabetes on plasma leptin and adiponectin in overweight Hispanic children
Koebnick C, Kelly LA, Lane CJ, Roberts CK, Shaibi GQ, Toledo-Corral CM, Davis JN, Weigensberg MJ and Goran MI
Short reports
HbA1c: the case for using estimated average glucose (eAG)
Philip Home
Hypertriglyceridaemia is associated with an increased likelihood of albuminuria in extreme duration (> 50 years) Type 1 diabetes Manuscript DME-2008-00150C Daousi, SC Bain, AH Barnett and GV Gill
Plasma triglycerides and LDL-cholesterol are related in a parabolic fashion in the general population and patients with type 2 diabetes mellitus: long-term follow-up results from the Hoorn study
M.C.G.J. Brouwers, J.M. Dekker, M.M.J. van Greevenbroek, C.J.H. van der Kallen, R.J. Heine, T.W.A. de Bruin and C.D.A. Stehouwer
Review
NICE guidance on Diabetes in pregnancy: management of diabetes and its complications from pre-conception to the postnatal period. NICE clinical guideline 63. London, March 2008.
Case Report
Renal Failure and Rhabdomyolysis Associated With Sitagliptin and Simvastatin Use
David P. Kao, Holbrook E Kohrt, John Kugler
Psychological aspects
A LONGITUDINAL STUDY OF AFFECTIVE AND ANXIETY DISORDERS, DEPRESSIVE AFFECT AND DIABETES DISTRESS in ADULTS WITH TYPE 2 DIABETES
Lawrence Fisher, Marilyn M. Skaff, Joseph T. Mullan, Patricia Arean, Russell Glasgow and Umesh Masharani
PREVALENCE AND REASONS FOR INSULIN REFUSAL in BANGLADESHI PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES IN EAST LONDON
Hamida Khan, Shawarna S Lasker, Tahseen A Chowdhury
Psychological aspects
Symptoms of Depression Prospectively Predict Poorer Self-Care in Patients with Type 2 Diabetes
JS Gonzalez, SA Safren, LM Delahanty, E Cagliero, DJ Wexler, JB Meigs and RW Grant
The personal cost of diabetic foot disease in developing world a study from Pakistan.
Syed Mansoor Ali, Aslam Fareed, Syed Mujahid Humail, Abdul Basit, Muhammad Yakoob Ahmedani, Asher Fawwad, M. Phil and Zahid Miyan.
Treatment
Diabetes, Obesity and Metabolism
Review Articles
Current treatment of non-alcoholic fatty liver disease
Mohamed H. Ahmed Christopher D. Byrne
Literature Reviews
Risk factor assessment for new onset diabetes: literature review
George Bakris,Jack Stockert, Mark Molitch, Qian Zhou, Annette Champion, Peter Bacher James Sowers, on behalf of the STAR Investigators
Original Articles
Glimepiride upregulates eNOS activity and inhibits cytokine-induced NF-B activation through a phosphoinoside 3-kinaseAkt-dependent pathwayT. Jojima, K. Suzuki, N. Hirama, K. Uchida Y. Hattori
Excess glycaemic excursions after an oral glucose tolerance test compared with a mixed meal challenge and self-measured home glucose profiles: is the OGTT a valid predictor of postprandial hyperglycaemia and vice versa?
J. J. Meier, B. Baller, B. A. Menge, B. Gallwitz, W. E. Schmidt M. A. Nauck
Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction
C. L. Oltman, E. P. Davidson, L. J. Coppey, T. L. Kleinschmidt M. A. Yorek
Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients
D. S. H. Bell, G. L. Bakris J. B. McGill
Current treatment of non-alcoholic fatty liver disease
Mohamed H. Ahmed Christopher D. Byrne
Literature Reviews
Risk factor assessment for new onset diabetes: literature review
George Bakris,Jack Stockert, Mark Molitch, Qian Zhou, Annette Champion, Peter Bacher James Sowers, on behalf of the STAR Investigators
Original Articles
Glimepiride upregulates eNOS activity and inhibits cytokine-induced NF-B activation through a phosphoinoside 3-kinaseAkt-dependent pathwayT. Jojima, K. Suzuki, N. Hirama, K. Uchida Y. Hattori
Excess glycaemic excursions after an oral glucose tolerance test compared with a mixed meal challenge and self-measured home glucose profiles: is the OGTT a valid predictor of postprandial hyperglycaemia and vice versa?
J. J. Meier, B. Baller, B. A. Menge, B. Gallwitz, W. E. Schmidt M. A. Nauck
Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction
C. L. Oltman, E. P. Davidson, L. J. Coppey, T. L. Kleinschmidt M. A. Yorek
Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients
D. S. H. Bell, G. L. Bakris J. B. McGill
Diabetes, Obesity and Metabolism
Volume 10, Issue 7, July 2008
Review Articles
Sudden cardiac death: influence of diabetes
P. M. Spooner
pages 523–532
Cardiovascular drugs as antidiabetic agents: evidence for the prevention of type 2 diabetes
D. P. Macfarlane, K. R. Paterson M. Fisher
pages 533–544
Original Articles
Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency
J. C. N. Chan, R. Scott, J. C. Arjona Ferreira, D. Sheng, E. Gonzalez, M. J. Davies, P. P. Stein, K. D. Kaufman, J. M. Amatruda D. Williams-Herman
pages 545–555
Overnight CSII as supplement to oral antidiabetic drugs in Type 2 diabetes
T. Parkner, M. K. Møller, J. W. Chen, T. Laursen, C. Jørgensen, J. S. Smedegaard, T. Lauritzen J. S. Christiansen
pages 556–563
Pioglitazone attenuates fatty acidinduced oxidative stress and apoptosis in pancreatic -cells
Y. Saitoh, C. Chun-ping, K. Noma, H. Ueno, M. Mizuta M. Nakazato
pages 564–573
Salacia oblonga root decreases cardiac hypertrophy in Zucker diabetic fatty rats: inhibition of cardiac expression of angiotensin II type 1 receptor
T. H. Huang, L. He, Q. Qin, Q. Yang, G. Peng, M. Harada, Y. Qi, J. Yamahara, B. D. Roufogalis Y. Li
pages 574–585
Improved metabolic control by Ipomoea batatas (Caiapo) is associated with increased adiponectin and decreased fibrinogen levels in type 2 diabetic subjects
B. Ludvik, M. Hanefeld, G. Pacini
pages 586–592
Research Letters
Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide
M. Horowitz, T. Vilsbøll, M. Zdravkovic, M. Hammer, S. Madsbad
pages 593–596
Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin
R. C. T. Mori, S. M. Hirabara, A. E. Hirata, M. M. Okamoto U. F. Machado
pages 596–600
Plasma visfatin is reduced after aerobic exercise in early onset type 2 diabetes mellitus
I. Brema, M. Hatunic, F. Finucane, N. Burns, J. J. Nolan, D. Haider, M. Wolzt, B. Ludvik
pages 600–602
Review Articles
Sudden cardiac death: influence of diabetes
P. M. Spooner
pages 523–532
Cardiovascular drugs as antidiabetic agents: evidence for the prevention of type 2 diabetes
D. P. Macfarlane, K. R. Paterson M. Fisher
pages 533–544
Original Articles
Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency
J. C. N. Chan, R. Scott, J. C. Arjona Ferreira, D. Sheng, E. Gonzalez, M. J. Davies, P. P. Stein, K. D. Kaufman, J. M. Amatruda D. Williams-Herman
pages 545–555
Overnight CSII as supplement to oral antidiabetic drugs in Type 2 diabetes
T. Parkner, M. K. Møller, J. W. Chen, T. Laursen, C. Jørgensen, J. S. Smedegaard, T. Lauritzen J. S. Christiansen
pages 556–563
Pioglitazone attenuates fatty acidinduced oxidative stress and apoptosis in pancreatic -cells
Y. Saitoh, C. Chun-ping, K. Noma, H. Ueno, M. Mizuta M. Nakazato
pages 564–573
Salacia oblonga root decreases cardiac hypertrophy in Zucker diabetic fatty rats: inhibition of cardiac expression of angiotensin II type 1 receptor
T. H. Huang, L. He, Q. Qin, Q. Yang, G. Peng, M. Harada, Y. Qi, J. Yamahara, B. D. Roufogalis Y. Li
pages 574–585
Improved metabolic control by Ipomoea batatas (Caiapo) is associated with increased adiponectin and decreased fibrinogen levels in type 2 diabetic subjects
B. Ludvik, M. Hanefeld, G. Pacini
pages 586–592
Research Letters
Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide
M. Horowitz, T. Vilsbøll, M. Zdravkovic, M. Hammer, S. Madsbad
pages 593–596
Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin
R. C. T. Mori, S. M. Hirabara, A. E. Hirata, M. M. Okamoto U. F. Machado
pages 596–600
Plasma visfatin is reduced after aerobic exercise in early onset type 2 diabetes mellitus
I. Brema, M. Hatunic, F. Finucane, N. Burns, J. J. Nolan, D. Haider, M. Wolzt, B. Ludvik
pages 600–602
New England Journal Of Medicine
12th June 2008
Effects of Intensive Glucose Lowering in Type 2 Diabetes
The ACCORD Study Group
Intensive Blood Glucose Control and Vascular Outcomes in Patients
with Type 2 Diabetes
The ADVANCE Collaborative Group
Effects of Intensive Glucose Lowering in Type 2 Diabetes
The ACCORD Study Group
Intensive Blood Glucose Control and Vascular Outcomes in Patients
with Type 2 Diabetes
The ADVANCE Collaborative Group
Diabetes, Obesity and Metabolism
Volume 10, Issue s2, July 2008
Review Articles
Optimum management of type 2 diabetes timely introduction, optimization and intensification of basal insulin
G. Dailey
pages 5–13
Reaching glycaemic targets while minimizing hypoglycaemia in insulin-treated type 2 diabetes patients
C. Mathieu S. Robbrecht
pages 14–23
Insulin glargine in type 2 diabetes in everyday clinical practice: 7 years experience
S. A. Schreiber
pages 24–34
Insulin therapy in elderly patients with type 2 diabetes: the role of insulin glargine
H. U. Janka
pages 35–41
Insulin management in overweight or obese type 2 diabetes patients: the role of insulin glargine
M. Davies K. Khunti
pages 42–49
Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine
C. Bradley C. J. B. Gilbride
pages 50–65
The cost-effectiveness of insulin glargine vs. neutral protamine Hagedorn insulin in type 2 diabetes: a focus on health economics
P. Levin
pages 66–75
Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus
D. Raccah
pages 76–82
Beyond insulin replacement: addressing the additional needs of the diabetes patient
G. Dailey
pages 83–97
The publication of this supplement has been supported by an unrestricted educational grant from sanofi-aventis.
Review Articles
Optimum management of type 2 diabetes timely introduction, optimization and intensification of basal insulin
G. Dailey
pages 5–13
Reaching glycaemic targets while minimizing hypoglycaemia in insulin-treated type 2 diabetes patients
C. Mathieu S. Robbrecht
pages 14–23
Insulin glargine in type 2 diabetes in everyday clinical practice: 7 years experience
S. A. Schreiber
pages 24–34
Insulin therapy in elderly patients with type 2 diabetes: the role of insulin glargine
H. U. Janka
pages 35–41
Insulin management in overweight or obese type 2 diabetes patients: the role of insulin glargine
M. Davies K. Khunti
pages 42–49
Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine
C. Bradley C. J. B. Gilbride
pages 50–65
The cost-effectiveness of insulin glargine vs. neutral protamine Hagedorn insulin in type 2 diabetes: a focus on health economics
P. Levin
pages 66–75
Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus
D. Raccah
pages 76–82
Beyond insulin replacement: addressing the additional needs of the diabetes patient
G. Dailey
pages 83–97
The publication of this supplement has been supported by an unrestricted educational grant from sanofi-aventis.
Journal of Clinical Nursing
Volume 17:7b (July 2008)
The impact of type 1 diabetes and eating disorders: the perspective of individuals
Sharon Hillege, Barbara Beale, and Rose McMaster
pages 169–176
Autonomy through identification: a qualitative study of the process of identification used by people with type 2 diabetes
Albine Moser, Harry van der Bruggen, Cor Spreeuwenberg and Guy Widdershovenpages
pages 209–216
The impact of type 1 diabetes and eating disorders: the perspective of individuals
Sharon Hillege, Barbara Beale, and Rose McMaster
pages 169–176
Autonomy through identification: a qualitative study of the process of identification used by people with type 2 diabetes
Albine Moser, Harry van der Bruggen, Cor Spreeuwenberg and Guy Widdershovenpages
pages 209–216
Diabetes Technology and Therapeutics
VOL 10 ; PART 3.
WellDoc Mobile Diabetes Management Randomized Controlled Trial : Change in Clinical and Behavioral Outcomes and Patient and Physician Satisfaction
Quinn , C . C . ; Clough , S . S . ; Minor , J . M . ; Lender , D . ; Okafor , M . C . ; Gruber - Baldini , A .
pp. 160-168.
WellDoc Mobile Diabetes Management Randomized Controlled Trial : Change in Clinical and Behavioral Outcomes and Patient and Physician Satisfaction
Quinn , C . C . ; Clough , S . S . ; Minor , J . M . ; Lender , D . ; Okafor , M . C . ; Gruber - Baldini , A .
pp. 160-168.
Diabetes, Obesity and Metabolism
Original Articles
The relationship of glycaemic control and triglycerides in patients with diabetes mellitus: a PreCIS Database Study
M. B. Davidson, T. Hu, Guven Sain, B. Hoar, C. Stevenson B. J. Hoogwerf
Review Articles
Combination statinfibrate therapy: safety aspects
R. Franssen, M. Vergeer, E. S. G. Stroes J. J. P. Kastelein
Original Articles
Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency
J. C. N. Chan, R. Scott, J. C. Arjona Ferreira, D. Sheng, E. Gonzalez, M. J. Davies, P. P. Stein, K. D. Kaufman, J. M. Amatruda D. Williams-Herman
Family history of diabetes impacts on interactions between minimal model estimates of insulin sensitivity and glucose effectiveness
X. Lopez, C. Bouché, E. Tatro A. B. Goldfine
The relationship of glycaemic control and triglycerides in patients with diabetes mellitus: a PreCIS Database Study
M. B. Davidson, T. Hu, Guven Sain, B. Hoar, C. Stevenson B. J. Hoogwerf
Review Articles
Combination statinfibrate therapy: safety aspects
R. Franssen, M. Vergeer, E. S. G. Stroes J. J. P. Kastelein
Original Articles
Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency
J. C. N. Chan, R. Scott, J. C. Arjona Ferreira, D. Sheng, E. Gonzalez, M. J. Davies, P. P. Stein, K. D. Kaufman, J. M. Amatruda D. Williams-Herman
Family history of diabetes impacts on interactions between minimal model estimates of insulin sensitivity and glucose effectiveness
X. Lopez, C. Bouché, E. Tatro A. B. Goldfine
Monday, 30 June 2008
Diabetic Medicine
9th June 2008
Letter to the Editor
Short report
Investigation of Adducin 2 (beta) DNA polymorphisms in genetic predisposition to diabetic nephropathy in type 1 diabetes
D. Currie, A. P. Maxwell, D. Sadlier and A. J. McKnight and The Warren 3/ U. K. GoKin. D. Study Group
Review
RD Lawrence lecture Targeting GLP-1 release as a potential strategy for the therapy of type 2 diabetes
FM Gribble
Educational interventions for migrant South Asians with type 2 diabetes: a systematic review K Khunti, J Camosso-Stefinovic, M Carey, MJ Davies and MA Stone
Original articles
A 10-Year (1996-2005) prospective study of the incidence of type 1 diabetes in Moscow in the age-group 0-14 Years
E.A. Pronina, E.E. Petraikina, M.B. Antsiferov, O.V. Duchareva, A. Petrone, R. Buzzetti and P. Pozzilli
The Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban population of middle aged Swedish Individuals.
Martina Montagnana, Cristiano Fava, Peter M Nilsson, Gunnar Engström, Bo Hedblad, Giuseppe Lippi, Pietro Minuz, Göran Berglund, Olle Melander
Foot Infections in Diabetes (DFIs) in the Outpatient Setting: an Italian Multicentre Observational Survey
Silvano Esposito, Sebastiano Leone, Silvana Noviello, Marco Fiore, Filomena Ianniello, Francesca Maria Felaco, Fabio Romagnoli, Ennio Sarli
Leptin - a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known type 2 diabetes
M. Wallander, S. Söderberg and A. Norhammar
Letter to the Editor
Short report
Investigation of Adducin 2 (beta) DNA polymorphisms in genetic predisposition to diabetic nephropathy in type 1 diabetes
D. Currie, A. P. Maxwell, D. Sadlier and A. J. McKnight and The Warren 3/ U. K. GoKin. D. Study Group
Review
RD Lawrence lecture Targeting GLP-1 release as a potential strategy for the therapy of type 2 diabetes
FM Gribble
Educational interventions for migrant South Asians with type 2 diabetes: a systematic review K Khunti, J Camosso-Stefinovic, M Carey, MJ Davies and MA Stone
Original articles
A 10-Year (1996-2005) prospective study of the incidence of type 1 diabetes in Moscow in the age-group 0-14 Years
E.A. Pronina, E.E. Petraikina, M.B. Antsiferov, O.V. Duchareva, A. Petrone, R. Buzzetti and P. Pozzilli
The Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban population of middle aged Swedish Individuals.
Martina Montagnana, Cristiano Fava, Peter M Nilsson, Gunnar Engström, Bo Hedblad, Giuseppe Lippi, Pietro Minuz, Göran Berglund, Olle Melander
Foot Infections in Diabetes (DFIs) in the Outpatient Setting: an Italian Multicentre Observational Survey
Silvano Esposito, Sebastiano Leone, Silvana Noviello, Marco Fiore, Filomena Ianniello, Francesca Maria Felaco, Fabio Romagnoli, Ennio Sarli
Leptin - a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known type 2 diabetes
M. Wallander, S. Söderberg and A. Norhammar
New England Journal of Medicine
12th June 2008
Editorial
Intensive Glycemic Control in the ACCORD and ADVANCE Trials R.G. Dluhy and G.T. McMahon
Original Articles
Effects of Intensive Glucose Lowering in Type 2 Diabetes
The ACCORD Study Group
Intensive Blood Glucose Control and Vascular Outcomes
in Patients with Type 2 Diabetes
The ADVANCE Collaborative Group
Glycemic Targets and Cardiovascular Disease
Perspective
Redefining Quality -- Implications of Recent Clinical Trials
Editorial
Intensive Glycemic Control in the ACCORD and ADVANCE Trials R.G. Dluhy and G.T. McMahon
Original Articles
Effects of Intensive Glucose Lowering in Type 2 Diabetes
The ACCORD Study Group
Intensive Blood Glucose Control and Vascular Outcomes
in Patients with Type 2 Diabetes
The ADVANCE Collaborative Group
Glycemic Targets and Cardiovascular Disease
Perspective
Redefining Quality -- Implications of Recent Clinical Trials
Labels:
Big4,
NEJM [journal]
BMJ
7th June 2008
Letters
Screen women with gestational diabetes for type 2 diabetes
Mark Sillender
Self monitoring of blood glucose: the cost to patients
Monika M Safford and Louise B Russell
Why patients who self monitor glucose might be more depressed
Lucy M Candib
Practice
Management of type 2 diabetes: summary of updated NICE guidance
Philip Home, Jonathan Mant, Jose Diaz, Claire Turner on behalf of the Guideline Development Group
Commentary: controversies in NICE guidance on management of type 2 diabetes
Stephen Atkin and Christopher Walton
Letters
Screen women with gestational diabetes for type 2 diabetes
Mark Sillender
Self monitoring of blood glucose: the cost to patients
Monika M Safford and Louise B Russell
Why patients who self monitor glucose might be more depressed
Lucy M Candib
Practice
Management of type 2 diabetes: summary of updated NICE guidance
Philip Home, Jonathan Mant, Jose Diaz, Claire Turner on behalf of the Guideline Development Group
Commentary: controversies in NICE guidance on management of type 2 diabetes
Stephen Atkin and Christopher Walton
Labels:
Big4,
BMJ (journal)
BMJ
14th June 2008
Research
Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study
M Á Martínez-González, C de la Fuente-Arrillaga, J M Nunez-Cordoba, F J Basterra-Gortari, J J Beunza, Z Vazquez, S Benito, A Tortosa, and M Bes-Rastrollo
BMJ Jun 2008; 336: 1348 - 1351
Research
Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study
M Á Martínez-González, C de la Fuente-Arrillaga, J M Nunez-Cordoba, F J Basterra-Gortari, J J Beunza, Z Vazquez, S Benito, A Tortosa, and M Bes-Rastrollo
BMJ Jun 2008; 336: 1348 - 1351
Labels:
Big4,
BMJ (journal),
diet
Friday, 13 June 2008
New Library book
New in the Health Sciences Library - 2 copies of
Managing clinical problems in diabetes, edited by Trisha Dunning and Glenn Ward
Shelved at 616.462 DUN
Managing clinical problems in diabetes, edited by Trisha Dunning and Glenn Ward
Shelved at 616.462 DUN
Friday, 6 June 2008
Recent Diabetes articles in the Big 4
We have full text access to BMJ, NEJM and JAMA
Full text access to The Lancet is available two months after publication. Articles published within the last two months are available via interlibrary loan
Metabolic syndrome—what is the clinical usefulness?
...events or diabetes in elderly patients, shows that a fasting plasma glucose test is as good as or potentially better than a diagnosis of the metabolic syndrome for predicting diabetes. They also show that a diagnosis of the metabolic syndrome has negligible association with risk of cardiovascular disease; and that the whole is not greater than t...
The Lancet - 10:54 AM (4 hours ago)
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies
...disease and diabetes remains uncertain. We investigated to what extent metabolic syndrome and its individual components were related to risk for these two diseases in elderly populations.
The Lancet - 10:54 AM (4 hours ago)
[PRACTICE] Management of type 2 diabetes: summary of updated NICE guidance
BMJ current issue - 12:06 AM (14 hours ago)
[LETTERS] Screen women with gestational diabetes for type 2 diabetes
BMJ current issue - 12:06 AM (14 hours ago)
[PRACTICE] Commentary: controversies in NICE guidance on management of type 2 diabetes
BMJ current issue - 12:06 AM (14 hours ago)
CME: Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
(No abstract is available for this citation)
New England Journal of Medicine - Jun 4, 2008 (2 days ago)
ORIGINAL ARTICLE: Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
...type 2 diabetes and nephropathy received either aliskiren, an oral direct renin inhibitor, or placebo, in addition to the maximal recommended dose of losartan and optimal antihypertensive therapy. Aliskiren was associated with a reduction in the mean urinary albumin-to-creatinine ratio. This direct renin inhibitor may be renoprotective independe...
New England Journal of Medicine - Jun 4, 2008 (2 days ago)
EDITORIAL: Aliskiren and Dual Therapy in Type 2 Diabetes Mellitus
The discovery 110 years ago that crude kidney extract elicited a pressor reaction provided the first evidence of the existence of the renin-angiotensin-aldosterone system, a major vasoactive system,1 and the ...
New England Journal of Medicine - Jun 4, 2008 (2 days ago)
CLINICAL CROSSROADS: A 40-Year-Old Woman With Diabetes Contemplating Pregnancy After Gastric Bypass Surgery
...type 2 diabetes and chronic hypertension who has had a gastric bypass procedure and is planning to conceive. She would like to know whether she can continue using metformin during the pregnancy and also is concerned about the effect of the gastric bypass surgery. This article discusses the management of diabetes prior to and during pregnancy, in...
JAMA current issue - Jun 3, 2008 (3 days ago)
JAMA PATIENT PAGE: Pregnancy and Diabetes
JAMA current issue - Jun 3, 2008 (3 days ago)
ORIGINAL CONTRIBUTION: Patient-Important Outcomes in Registered Diabetes Trials
...efficacy of diabetes interventions persist, in part because randomized clinical trials (RCTs) have not measured their effect on patient-important outcomes, ie, death and quality of life (morbidity, pain, function). Objective To systematically determine the extent to which ongoing and future RCTs in diabetes will ascertain patient-important outc...
JAMA current issue - Jun 3, 2008 (3 days ago)
Department of Error
...diagnosis of diabetes: three population-based cross-sectional studies. Lancet 2008; 371: 736–43—In this Article (March 1), data in the sensitivity and specificity columns of were incorrect, as was the total number of participants above the cutoff of 5·6 mmol/L in the Australian Diabetes, Obesity and Lifestyle Study. The corrected version of the...
The Lancet - May 30, 2008 10:43 AM
CORRECTIONS: Gestational Diabetes -- Setting Limits, Exploring Treatments
...Gestational Diabetes -- Setting Limits, Exploring Treatments . In the paragraph that begins "Also in this issue of the Journal..." (page 2062), the final sentence should have read, "Rates of ...
New England Journal of Medicine - May 28, 2008 10:20 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI--Reply
JAMA current issue - May 27, 2008 9:27 PM
BOOK AND MEDIA REVIEWS: Levin and O'Neal's The Diabetic Foot
JAMA current issue - May 27, 2008 9:27 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM
Full text access to The Lancet is available two months after publication. Articles published within the last two months are available via interlibrary loan
Metabolic syndrome—what is the clinical usefulness?
...events or diabetes in elderly patients, shows that a fasting plasma glucose test is as good as or potentially better than a diagnosis of the metabolic syndrome for predicting diabetes. They also show that a diagnosis of the metabolic syndrome has negligible association with risk of cardiovascular disease; and that the whole is not greater than t...
The Lancet - 10:54 AM (4 hours ago)
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies
...disease and diabetes remains uncertain. We investigated to what extent metabolic syndrome and its individual components were related to risk for these two diseases in elderly populations.
The Lancet - 10:54 AM (4 hours ago)
[PRACTICE] Management of type 2 diabetes: summary of updated NICE guidance
BMJ current issue - 12:06 AM (14 hours ago)
[LETTERS] Screen women with gestational diabetes for type 2 diabetes
BMJ current issue - 12:06 AM (14 hours ago)
[PRACTICE] Commentary: controversies in NICE guidance on management of type 2 diabetes
BMJ current issue - 12:06 AM (14 hours ago)
CME: Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
(No abstract is available for this citation)
New England Journal of Medicine - Jun 4, 2008 (2 days ago)
ORIGINAL ARTICLE: Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
...type 2 diabetes and nephropathy received either aliskiren, an oral direct renin inhibitor, or placebo, in addition to the maximal recommended dose of losartan and optimal antihypertensive therapy. Aliskiren was associated with a reduction in the mean urinary albumin-to-creatinine ratio. This direct renin inhibitor may be renoprotective independe...
New England Journal of Medicine - Jun 4, 2008 (2 days ago)
EDITORIAL: Aliskiren and Dual Therapy in Type 2 Diabetes Mellitus
The discovery 110 years ago that crude kidney extract elicited a pressor reaction provided the first evidence of the existence of the renin-angiotensin-aldosterone system, a major vasoactive system,1 and the ...
New England Journal of Medicine - Jun 4, 2008 (2 days ago)
CLINICAL CROSSROADS: A 40-Year-Old Woman With Diabetes Contemplating Pregnancy After Gastric Bypass Surgery
...type 2 diabetes and chronic hypertension who has had a gastric bypass procedure and is planning to conceive. She would like to know whether she can continue using metformin during the pregnancy and also is concerned about the effect of the gastric bypass surgery. This article discusses the management of diabetes prior to and during pregnancy, in...
JAMA current issue - Jun 3, 2008 (3 days ago)
JAMA PATIENT PAGE: Pregnancy and Diabetes
JAMA current issue - Jun 3, 2008 (3 days ago)
ORIGINAL CONTRIBUTION: Patient-Important Outcomes in Registered Diabetes Trials
...efficacy of diabetes interventions persist, in part because randomized clinical trials (RCTs) have not measured their effect on patient-important outcomes, ie, death and quality of life (morbidity, pain, function). Objective To systematically determine the extent to which ongoing and future RCTs in diabetes will ascertain patient-important outc...
JAMA current issue - Jun 3, 2008 (3 days ago)
Department of Error
...diagnosis of diabetes: three population-based cross-sectional studies. Lancet 2008; 371: 736–43—In this Article (March 1), data in the sensitivity and specificity columns of were incorrect, as was the total number of participants above the cutoff of 5·6 mmol/L in the Australian Diabetes, Obesity and Lifestyle Study. The corrected version of the...
The Lancet - May 30, 2008 10:43 AM
CORRECTIONS: Gestational Diabetes -- Setting Limits, Exploring Treatments
...Gestational Diabetes -- Setting Limits, Exploring Treatments . In the paragraph that begins "Also in this issue of the Journal..." (page 2062), the final sentence should have read, "Rates of ...
New England Journal of Medicine - May 28, 2008 10:20 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI--Reply
JAMA current issue - May 27, 2008 9:27 PM
BOOK AND MEDIA REVIEWS: Levin and O'Neal's The Diabetic Foot
JAMA current issue - May 27, 2008 9:27 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM
Labels:
Big4,
cardiovascular,
diabetic foot,
Metabolism.,
NICE,
pregnancy,
treatment,
trials
Best Practice & Research Clinical Endocrinology & Metabolism Volume 22, Issue 3, (June 2008)
Pathophysiology of insulin resistance in subjects born small for gestational age Pages 503-515 Jacques Beltrand and Claire Lévy-Marchal
Labels:
insulin resistance,
paediatric
Foresight Training Resource Pack - management of diabetes in the community
2 training videos here on management of diabetes in the community. c. 3 mins each the show two different approaches (good and bad) to dealing with a patient with bipolar disorder recently diagnosed with diabetes. Suitable for group discussions.
Foresight Training Resource PackBy Health Management Specialist Library
The National Patient Safety Agency (NPSA) has developed this resourceto support nurses and midwives, working in all care settings to improve awareness of the factors that combine to increase the likelihood of patient safety incidents. It has been specifically designed to be flexible, so that it can be used in team meetings, handovers, mandatory training sessions and stand alone sessions, facilitated by members of staff. (NPSA press release)
Foresight Training Resource PackBy Health Management Specialist Library
The National Patient Safety Agency (NPSA) has developed this resourceto support nurses and midwives, working in all care settings to improve awareness of the factors that combine to increase the likelihood of patient safety incidents. It has been specifically designed to be flexible, so that it can be used in team meetings, handovers, mandatory training sessions and stand alone sessions, facilitated by members of staff. (NPSA press release)
Labels:
education
Subscribe to:
Posts (Atom)
